StockData
MetaVia Inc. logo

MetaVia Inc. (MTVA) stock

MTVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.25+0.04 (+3.73%)

Close on Nov 17, 2026Market cap $8.24MP/E –Yield –

MetaVia operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

MetaVia's operating income for the twelve months ending Jun 30, 2026 was -$14.93M. For fiscal 2025 it was -$13.71M. The highest annual figure on record is -$266.00K in fiscal 2014.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$13.71M–
FY2024Dec 31, 2024-$28.81M–
FY2023Dec 31, 2023-$15.89M–
FY2022Dec 31, 2022-$19.63M–
FY2021Dec 31, 2021-$15.30M–
FY2020Dec 31, 2020-$29.72M–
FY2019Dec 31, 2019-$20.18M–
FY2018Dec 31, 2018-$15.49M–
FY2017Dec 31, 2017-$33.12M–
FY2016Dec 31, 2016-$14.70M–
FY2015Dec 31, 2015-$8.08M–
FY2014Dec 31, 2014-$266.00K–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$5.39M–
Q1 FY2026Mar 31, 2026-$4.03M–
Q4 FY2025Dec 31, 2025-$2.05M–
Q3 FY2025Sep 30, 2025-$3.48M–
Q2 FY2025Jun 30, 2025-$4.30M–
Q1 FY2025Mar 31, 2025-$3.89M–
Q4 FY2024Dec 31, 2024-$5.59M–
Q3 FY2024Sep 30, 2024-$6.26M–
Q2 FY2024Jun 30, 2024-$10.08M–
Q1 FY2024Mar 31, 2024-$6.88M–
Q4 FY2023Dec 31, 2023-$5.67M–
Q3 FY2023Sep 30, 2023-$3.89M–
Q2 FY2023Jun 30, 2023-$3.81M–
Q1 FY2023Mar 31, 2023-$2.52M–
Q4 FY2022Dec 31, 2022-$10.43M–
Q3 FY2022Sep 30, 2022-$3.10M–
Q2 FY2022Jun 30, 2022-$3.22M–
Q1 FY2022Mar 31, 2022-$2.88M–
Q4 FY2021Dec 31, 2021-$4.58M–
Q3 FY2021Sep 30, 2021-$3.46M–
Q2 FY2021Jun 30, 2021-$3.93M–
Q1 FY2021Mar 31, 2021-$3.33M–
Q4 FY2020Dec 31, 2020-$19.52M–
Q3 FY2020Sep 30, 2020-$3.06M–
Q2 FY2020Jun 30, 2020-$2.39M–
Q1 FY2020Mar 31, 2020-$4.75M–
Q4 FY2019Dec 31, 2019-$12.19M–
Q3 FY2019Sep 30, 2019-$3.65M–
Q2 FY2019Jun 30, 2019-$1.89M–
Q1 FY2019Mar 31, 2019-$2.45M–
Q4 FY2018Dec 31, 2018-$3.30M–
Q3 FY2018Sep 30, 2018-$5.91M–
Q2 FY2018Jun 30, 2018-$6.53M–
Q1 FY2018Mar 31, 2018-$7.06M–
Q4 FY2017Dec 31, 2017-$6.57M–
Q3 FY2017Sep 30, 2017-$8.54M–
Q2 FY2017Jun 30, 2017-$10.52M–
Q1 FY2017Mar 31, 2017-$7.50M–
Q4 FY2016Dec 31, 2016-$7.23M–
Q3 FY2016Sep 30, 2016-$3.40M–

More MetaVia figures

See a number that looks wrong?